210 Biomarkers
| ID | Biomarker | Location | Application | Reference |
|---|---|---|---|---|
| 456 | hsa-mir-221 | No Data | Diagnosis, Prognosis | Pu XX et al. J Gastroenterol Hepatol. 2010 |
| 481 | hsa-mir-195 | Colon, Rectum | Prognosis | Wang X et al. Med Oncol. 2012 |
| 483 | hsa-mir-125b | Colon, Rectum | Prognosis | Nishida N et al. Int J Oncol. 2011 |
| 526 | hsa-mir-150 | No Data | Prognosis, Treatment | Ma Y et al. Gut. 2012 |
| 541 | hsa-mir-10b | No Data | Prognosis | Nishida N et al. Ann Surg Oncol. 2012 |
| 553 | hsa-mir-22 | Colon, Rectum | Prognosis | Zhang G et al. Med Oncol. 2012 |
| 559 | hsa-mir-143 | Colon, Rectum | Prognosis, Treatment | Pichler M et al. Br J Cancer. 2012 |
| 573 | hsa-mir-200c | Rectum | Diagnosis, Treatment | Kur K et al. Gut. 2013 |
| 579 | hsa-mir-92a | Colon, Rectum | Prognosis | Zhou T et al. Int J Colorectal Dis. 2013 |
| 598 | hsa-mir-144 | No Data | Prognosis | Iwaya T et al. Carcinogenesis. 2012 |
| 602 | hsa-mir-148a | No Data | Prognosis | Takahashi M et al. PLoS One. 2012 |
| 606 | hsa-mir-429 | Colon, Rectum | Prognosis | Li J et al. Cancer Lett. 2013 |
| 624 | hsa-mir-362-3p | Colon, Rectum | Prognosis | Christensen LL et al. Int J Cancer. 2013 |
| 639 | hsa-mir-182 | Colon, Rectum | Prognosis, Treatment | Liu H et al. Int J Colorectal Dis. 2013 |
| 655 | hsa-mir-21 | Colon, Rectum | Diagnosis, Prognosis | Toiyama Y et al. J Natl Cancer Inst. 2013 |
| 678 | hsa-mir-625 | Colon, Rectum | Prognosis, Treatment | Lou X et al. J Surg Oncol. 2013 |
| 689 | hsa-mir-21 | Colon, Rectum | Prognosis | Menéndez P et al. J Surg Oncol. 2013 |
| 690 | hsa-mir-200c | No Data | Prognosis | Toiyama Y et al. Ann Surg. 2014 |
| 711 | hsa-mir-32 | No Data | Prognosis | Wu W et al. Genes Chromosomes Cancer. 2013 |
| 718 | hsa-mir-21 | No Data | Prognosis | Ferraro A et al. Epigenetics. 2014 |
| 719 | hsa-mir-183 | No Data | Prognosis | Zhou T et al. Eur J Gastroenterol Hepatol. 2014 |
| 728 | hsa-mir-31 | Colon, Rectum | Diagnosis, Treatment | Nosho K et al. Carcinogenesis. 2014 |
| 732 | hsa-mir-25 | No Data | Prognosis | Li X et al. Med Oncol. 2014 |
| 733 | hsa-mir-30b | No Data | Prognosis, Treatment | Liao WT et al. J Pathol. 2014 |
| 734 | hsa-mir-218 | No Data | Prognosis | Yu H et al. Int J Clin Exp Pathol. 2013 |
| 737 | hsa-mir-133b | No Data | Prognosis | Duan FT et al. Mol Cancer. 2013 |
| 744 | hsa-mir-449a | Colon, Rectum | Prognosis | Chen S et al. Oncol Left. 2014 |
| 746 | hsa-mir-429 | No Data | Treatment | Sun Y et al. Mol Cell Biochem. 2014 |
| 754 | hsa-mir-126 | Colon, Rectum | Prognosis | Liu Y et al. Genes Chromosomes Cancer. 2014 |
| 761 | hsa-mir-214 | No Data | Prognosis, Treatment | Chen DL et al. Hepatology. 2014 |
| 762 | hsa-mir-210 | Colon, Rectum | Prognosis | Qu A et al. PLoS One. 2014 |
| 770 | hsa-mir-20a | No Data | Prognosis | Zhang GJ et al. Mol Med Rep. 2014 |
| 803 | hsa-mir-205 | Colon, Rectum | Diagnosis, Prognosis | Orang AV et al. Asian Pac J Cancer Prev. 2014 |
| 804 | hsa-mir-345 | No Data | Prognosis | Schou JV et al. PLoS One. 2014 |
| 813 | hsa-mir-630 | No Data | Prognosis | Chu D et al. Tumour Biol. 2014 |
| 850 | hsa-mir-27a | No Data | Treatment | Bao Y et al. PLoS One. 2014 |
| 851 | hsa-mir-133a | Colon, Rectum | Prognosis | Wang LL et al. World J Gastroenterol. 2014 |
| 861 | hsa-mir-194 | Colon | Diagnosis | Zhao HJ et al. Theranostics. 2014 |
| 866 | hsa-mir-378 | Colon | Prognosis | Wang KY et al. IUBMB Life. 2014 |
| 870 | hsa-mir-376a | Colon, Rectum | Prognosis | Mo ZH et al. Asian Pac J Cancer Prev. 2014 |
| 872 | hsa-mir-196a, hsa-mir-196b | Colon | Prognosis | Ge J et al. Cancer Cell Int. 2014 |
| 878 | hsa-mir-1269a | Colon | Treatment | Bu P et al. Nat Commun. 2015 |
| 884 | hsa-mir-217 | No Data | Prognosis, Treatment | Wang B et al. BMC Cancer. 2015 |
| 887 | hsa-mir-154 | No Data | Prognosis | Kai Y et al. World J Surg Oncol. 2015 |
| 889 | hsa-mir-19a | No Data | Prognosis | Matsumura T et al. Br J Cancer. 2015 |
| 898 | hsa-mir-34a | No Data | Treatment | Lu G et al. Exp Mol Pathol. 2015 |
| 906 | hsa-mir-17-3p | Colon, Rectum | Prognosis | Li J et al. Sci Rep. 2015 |
| 920 | hsa-mir-144 | No Data | Treatment | Cai SD et al. Mol Med Rep. 2015 |
| 921 | hsa-mir-29b | No Data | Diagnosis | Li L et al. Technol Cancer Res Treat. 2016 |
| 934 | hsa-mir-203 | Colon, Rectum | Prognosis | Hur K et al. Gut. 2017 |
| 941 | hsa-mir-96 | No Data | Prognosis | Sun Y et al. Oncotarget. 2016 |
| 942 | hsa-mir-203 | No Data | Prognosis | Sun Y et al. Oncotarget. 2016 |
| 943 | hsa-mir-141 | No Data | Prognosis | Sun Y et al. Oncotarget. 2016 |
| 948 | hsa-mir-21 | Colon, Rectum | Diagnosis, Prognosis | Wang W et al. Eur J Cancer Care (Engl). 2016 |
| 951 | hsa-mir-543 | No Data | Diagnosis, Prognosis | Fan C et al. Oncotarget. 2016 |
| 969 | hsa-mir-517a | No Data | Prognosis | Ma W et al. Oncol Lett. 2016 |
| 976 | hsa-mir-135a-5p | Colon, Rectum | Diagnosis | Wang Q et al. Ann Clin Biochem. 2017 |
| 985 | hsa-mir-31 | No Data | Prognosis | Caramés C et al. Int J Mol Sci. 2016 |
| 993 | hsa-mir-21 | Colon, Rectum | Diagnosis | Bastaminejad S et al. Iran Biomed J. 2017 |
| 999 | hsa-mir-449a | Colon | Prognosis | Sun X et al. Oncotarget. 2016 |
| 1003 | hsa-mir-1290 | Colon | Diagnosis, Prognosis | Imaoka H et al. Ann Oncol. 2016 |
| 1007 | hsa-mir-320 | No Data | Diagnosis | Tadano T et al. World J Gastrointest Oncol. 2016 |
| 1010 | hsa-mir-188-3p | Colon, Rectum | Prognosis | Pichler M et al. Clin Cancer Res. 2017 |
| 1011 | hsa-mir-188-3p | Colon, Rectum | Prognosis | Pichler M et al. Clin Cancer Res. 2017 |
| 1013 | hsa-mir-122, hsa-mir-200 | Colon, Rectum | Prognosis | Maierthaler M et al. Int J Cancer. 2017 |
| 1017 | hsa-mir-203 | No Data | Diagnosis, Prognosis | Fu Q et al. Tumour Biol. 2016 |
| 1026 | hsa-mir-137 | Colon | Prognosis | Huang YC et al. Oncotarget. 2016 |
| 1035 | hsa-mir-152 | No Data | Prognosis | Wang Y et al. Zhonghua Zhong Liu Za Zhi. 2016 |
| 1048 | hsa-mir-6826, hsa-mir-6875 | Colon, Rectum | Treatment | Kijima T et al. Oncol Rep. 2017 |
| 1050 | hsa-mir-198, hsa-mir-765, hsa-mir-630, hsa-mir-371-5p, hsa-mir-575, hsa-mir-202, hsa-mir-513a-5p | Colon, Rectum | Treatment | Zhu Y et al. Oncotarget. 2017 |
| 1054 | hsa-mir-181c | Colon, Rectum | Prognosis | Yamazaki N et al. Oncotarget. 2017 |
| 1073 | hsa-mir-196b | Colon, Rectum | Diagnosis, Prognosis | Xu C et al. Biomed Rep. 2017 |
| 1085 | hsa-mir-19a-3p, hsa-mir-21-5p, hsa-mir-425-5p | Colon, Rectum | Diagnosis | Zhu M et al. Oncotarget. 2017 |
| 1089 | hsa-mir-375 | Colon, Rectum | Diagnosis | Wei R et al. Oncotarget. 2017 |
| 1093 | hsa-mir-296 | Colon, Rectum | Prognosis | He Z et al. BMC Cancer. 2017 |
| 1099 | hsa-mir-96-5p, hsa-mir-149 | Colon, Rectum | Diagnosis | Li J et al. J Cell Mol Med. 2017 |
| 1104 | hsa-mir-139-5p | Colon, Rectum | Prognosis | Miyoshi J et al. Sci Rep. 2017 |
| 1134 | hsa-mir-203 | Colon, Rectum | Prognosis | Shao Y et al. Cell Physiol Biochem. 2017 |
| 1135 | hsa-mir-548c-5p | Colon | Diagnosis, Prognosis | Tao, F et al. J Cell Biochem. 2018 |
| 1137 | hsa-mir-21 | No Data | No Data | Shao, Y et al. Carcinogenesis. 2018 |
| 1142 | hsa-mir-488 | No Data | No Data | Wang, Y B et al. Am J Physiol Cell Physiol. 2019 |
| 1150 | hsa-mir-7 | Colon, Rectum | Prognosis | Qin, A et al. Int J Mol Med. 2018 |
| 1166 | hsa-mir-221 | No Data | Diagnosis, Prognosis | Youssef, O et al. Clin Lab. 2018 |
| 1168 | hsa-mir-17, hsa-mir-92 | Rectum | Prognosis | Kral, J et al. Carcinogenesis. 2018 |
| 1170 | hsa-mir-340-5p | No Data | Prognosis | Di Martino, S et al. Eur Rev Med Pharmacol Sci. 2018 |
| 1176 | hsa-mir-486-5p | No Data | Treatment | Liu, X et al. Cell Death Dis. 2018 |
| 1182 | hsa-mir-3666 | Colon, Rectum | Prognosis | Yang, D et al. Mol Med Rep. 2018 |
| 1187 | hsa-mir-101 | No Data | Diagnosis, Prognosis | He, D et al. Med Sci Monit. 2018 |
| 1191 | hsa-mir-210, hsa-mir-21, hsa-mir-126 | No Data | Diagnosis, Prognosis | Sabry, D et al. Mol Cell Biochem. 2019 |
| 1221 | hsa-mir-15b | No Data | Prognosis, Treatment | Ji, D et al. Stem Cell Reports. 2018 |
| 1227 | hsa-mir-103a-3p, hsa-mir-127-3p, hsa-mir-151a-5p, hsa-mir-17-5p, hsa-mir-181a-5p, hsa-mir-18a-5p, hsa-mir-18b-5p | Colon, Rectum | Diagnosis | Zhang, H et al. Gene. 2019 |
| 1236 | hsa-mir-145 | Colon, Rectum | No Data | Tang, H et al. J Cell Biochem. 2018 |
| 1257 | hsa-mir-1256 | Colon, Rectum | Prognosis | Liu, Z Y et al. Eur Rev Med Pharmacol Sci. 2018 |
| 1276 | hsa-mir-25-3p | Colon, Rectum | No Data | Zeng, Z et al. Nat Commun. 2018 |
| 1282 | hsa-mir-21, hsa-mir-24 | No Data | Prognosis | Hao, J P et al. Eur Rev Med Pharmacol Sci. 2018 |
| 1283 | hsa-mir-199a | No Data | Diagnosis, Prognosis | Tan, H Y et al. Eur Rev Med Pharmacol Sci. 2018 |
| 1288 | hsa-mir-20a, hsa-mir-486 | Colon, Rectum | No Data | Yang, Q et al. J Cancer Res Ther. 2018 |
| 1316 | hsa-mir-410 | No Data | Prognosis | Wang, W et al. Oncol Lett. 2019 |
| 1320 | hsa-mir-1290, hsa-mir-320d | No Data | Diagnosis | Liu, X et al. J Cancer. 2019 |
| 1363 | hsa-mir-124 | No Data | Diagnosis | Qin, Z et al. Onco Targets Ther. 2019 |
| 1367 | hsa-mir-487b | Colon, Rectum | Diagnosis | Chen, X et al. Cancer Med. 2019 |
| 1376 | hsa-mir-144 | Colon, Rectum | Prognosis | Jiang, Y et al. Oncol Rep. 2019 |
| 1383 | hsa-mir-30a-5p | Colon, Rectum | Diagnosis, Prognosis | Sun, Y et al. Cancer Biomark. 2019 |
| 1404 | hsa-mir-491-5p | Colon, Rectum | Diagnosis, Prognosis | Lu, L et al. Cancer Manag Res. 2019 |
| 1410 | hsa-mir-944 | No Data | Prognosis | Tang, J T et al. J Cell Mol Med. 2019 |
| 1419 | hsa-mir-122 | No Data | Prognosis | Dai, M et al. Oncol Lett. 2019 |
| 1420 | hsa-mir-143-3p, hsa-mir-424-5p | Colon, Rectum | No Data | Sahami-Fard, M H et al. Cancer Biomark. 2019 |
| 1422 | hsa-mir-128-3p | Colon, Rectum | No Data | Liu, T et al. Mol Cancer. 2019 |
| 1426 | specific miRNAs | No Data | Prognosis | Sabarimurugan, S et al. Medicine (Baltimore). 2019 |
| 1432 | hsa-mir-208a-3p | Colon, Rectum | Diagnosis, Treatment | Wu, H et al. Biosci Rep. 2019 |
| 1433 | hsa-mir-142-3p | Colon, Rectum | Diagnosis, Prognosis | Gao, W et al. J Int Med Res. 2019 |
| 1435 | hsa-mir-144-3p, hsa-mir-425-5p, hsa-mir-1260b | Colon, Rectum | Diagnosis | Tan, Y et al. Cancer Epidemiol. 2019 |
| 1445 | hsa-mir-26a | Colon, Rectum | Prognosis | Coronel-Hernandez, J et al. Cancer Cell Int. 2019 |
| 1452 | hsa-mir-21-3p | Colon, Rectum | Prognosis | Jiao W et al. Int J Cancer. 2017 |
| 1455 | hsa-mir-451a | Rectum | Prognosis | Kelley KA et al. Ann Surg. 2017 |
| 1464 | hsa-mir-125a | Colon, Rectum | Prognosis | Liang L et al. Cell Death Dis. 2017 |
| 1477 | hsa-mir-216a-3p | Colon, Rectum | Prognosis | Wang D et al. J Cell Biochem. 2018 |
| 1495 | hsa-mir-190a-3p | Colon, Rectum | Prognosis | Motieghader H et al. Mol Biosyst. 2017 |
| 1498 | hsa-mir-194 | Colon, Rectum | Prognosis | D'Angelo E et al. J Clin Pathol. 2017 |
| 1502 | hsa-mir-222 | Colon, Rectum | Prognosis | Khoshinani HM et al. Jpn J Radiol. 2017 |
| 1505 | hsa-mir-7d-5p | Colon, Rectum | Prognosis | Tsunekuni K et al. Oncotarget. 2017 |
| 1521 | hsa-mir-552 | Colon, Rectum | Prognosis | Cao J et al. Oncol Lett. 2017 |
| 1540 | hsa-mir-133b | Colon, Rectum | Prognosis | Wang X et al. Oncotarget. 2017 |
| 1560 | hsa-mir-760 | Colon, Rectum | Prognosis, Treatment | Li X et al. Mol Med Rep. 2017 |
| 1570 | hsa-mir-19b-1 | Colon, Rectum | Prognosis | Cruz-Gil S et al. J Lipid Res. 2018 |
| 1580 | hsa-mir-203 | Colon, Rectum | Prognosis | Takano Y et al. Oncotarget. 2017 |
| 1581 | hsa-mir-143 | Colon, Rectum | Diagnosis | Hiyoshi Y et al. Oncotarget. 2017 |
| 1598 | hsa-mir-375 | Rectum | Prognosis | Conde-Muiño R et al. Oncotarget. 2017 |
| 1600 | hsa-mir-27a-3p | Colon, Rectum | Prognosis, Treatment | Liang J et al. Oncotarget. 2017 |
| 1615 | hsa-mir-320d | Rectum | Prognosis | Mjelle R et al. Oncotarget. 2017 |
| 1618 | hsa-mir-24-2 | Colon, Rectum | Prognosis | He HW et al. Cancer Biomark. 2018 |
| 1637 | hsa-mir-6869-5p | Colon, Rectum | Diagnosis | Yan S et al. J Cell Physiol. 2017 |
| 1639 | hsa-mir-31-3p | Colon, Rectum | Diagnosis | Pugh S et al. Oncotarget. 2017 |
| 1643 | hsa-mir-200c | Colon, Rectum | Diagnosis | Karimi Dermani F et al. J Gastrointest Cancer. 2017 |
| 1645 | hsa-mir-495 | Colon, Rectum | Prognosis | Yan L et al. Biomed Pharmacother. 2017 |
| 1648 | hsa-mir-193b | Colon, Rectum | Diagnosis | Liu KL et al. Clin Lab. 2017 |
| 1655 | hsa-mir-6803-5p | Colon, Rectum | Diagnosis, Prognosis | Yan S et al. J Cell Biochem. 2018 |
| 1661 | hsa-mir-449a | Colon, Rectum | Diagnosis, Treatment | Sun X et al. Oncotarget. 2016 |
| 1675 | hsa-mir-21 | Colon, Rectum | Prognosis | Bhome R et al. Aging (Albany NY). 2018 |
| 1682 | hsa-mir-494 | Colon, Rectum | Prognosis, Treatment | Zhang Y et al. Mol Cancer. 2018 |
| 1688 | hsa-mir-186-5p | Colon, Rectum | Treatment | Li J et al. Arch Biochem Biophys. 2018 |
| 1690 | hsa-mir-873 | Colon, Rectum | Prognosis, Treatment | Gong H et al. Oncol Rep. 2018 |
| 1709 | hsa-mir-155 | Colon, Rectum | Prognosis | Liu N et al. Eur Rev Med Pharmacol Sci. 2018 |
| 1710 | hsa-mir-17-5p | Colon, Rectum | Prognosis | Fu F et al. Transl Oncol. 2018 |
| 1723 | hsa-mir-31-3p | Colon, Rectum | Treatment | Laurent-Puig P et al. Clin Cancer Res. 2019 |
| 1751 | hsa-mir-34a | Colon, Rectum | Diagnosis | Zhang Q et al. Am J Cancer Res. 2018 |
| 1754 | hsa-mir-433 | Colon, Rectum | Prognosis | Zhang J et al. Oncol Lett. 2018 |
| 1759 | hsa-mir-106b | Colon, Rectum | Prognosis | Zhao Y et al. Cancer Biomark. 2018 |
| 1767 | hsa-mir-519d-3p | Colon, Rectum | Prognosis | Ye X et al. Biomed Pharmacother. 2018 |
| 1774 | hsa-mir-340-5p | Colon, Rectum | Prognosis, Treatment | Yang L et al. Eur Rev Med Pharmacol Sci. 2018 |
| 1794 | hsa-mir-494 | Colon, Rectum | Prognosis | Xiang Z et al. Oncotarget. 2017 |
| 1807 | hsa-mir-375, hsa-mir-133a-3p | Colon, Rectum | Prognosis | Weber D et al. Oncotarget. 2018 |
| 1810 | hsa-mir-139 | Colon, Rectum | Diagnosis | Wang YH et al. Clin Chim Acta. 2018 |
| 1818 | hsa-mir-552 | Colon, Rectum | Prognosis, Treatment | Wang N et al. Eur Rev Med Pharmacol Sci. 2018 |
| 1823 | hsa-mir-103 | Colon, Rectum | Diagnosis, Prognosis | Wang DS et al. Eur Rev Med Pharmacol Sci. 2018 |
| 1826 | hsa-mir-4903p | Colon, Rectum | Prognosis | Wang B et al. Int J Oncol. 2018 |
| 1835 | hsa-mir-28-5p | Colon, Rectum | Diagnosis, Prognosis | Tsiakanikas P et al. Clin Chem Lab Med. 2018 |
| 1841 | hsa-mir-200c | Colon, Rectum | Diagnosis, Prognosis | Tayel SI et al. Arch Biochem Biophys. 2018 |
| 1867 | hsa-mir-548c-5p | Colon, Rectum | Diagnosis, Prognosis | Peng ZY et al. J Cell Biochem. 2018 |
| 1875 | SNPs of sncRNAs, hsa-mir-196a | Colon, Rectum | Treatment | Pao JB et al. Int J Med Sci. 2018 |
| 1907 | hsa-mir-27b | Colon, Rectum | Prognosis, Treatment | Luo Y et al. Oncotarget. 2017 |
| 1908 | hsa-mir-519b-3p | Rectum | Prognosis | Luo J et al. Gene. 2018 |
| 1911 | hsa-mir-182 | Colon, Rectum | Diagnosis | Liu X et al. Cancer Manag Res. 2018 |
| 1912 | hsa-mir-27a, hsa-mir-130a | Colon, Rectum | Prognosis | Liu X et al. Cancer Epidemiol Biomarkers Prev. 2018 |
| 1913 | hsa-mir-490-3p | Colon, Rectum | Diagnosis, Prognosis | Liu X et al. J Cancer. 2018 |
| 1916 | hsa-mir-17 | Colon, Rectum | Diagnosis | Liu T et al. Cell Mol Biol (Noisy-le-grand). 2018 |
| 1919 | hsa-mir-155, beta-catenin | Colon, Rectum | Diagnosis, Treatment | Liu N et al. Eur Rev Med Pharmacol Sci. 2018 |
| 1937 | hsa-mir-150 | Colon, Rectum | Prognosis | Li C et al. Oncol Rep. 2018 |
| 1945 | hsa-mir-202-5p | Colon, Rectum | Prognosis, Treatment | Ke SB et al. Gene. 2018 |
| 1954 | hsa-mir-423 rs6505162 C>A | Colon, Rectum | Prognosis | Jia W et al. Medicine (Baltimore). 2018 |
| 1979 | hsa-mir-888 | Colon, Rectum | Prognosis | Gao SJ et al. Oncol Lett. 2018 |
| 1984 | hsa-mir-17-5p, hsa-mir-92a-3p | Colon, Rectum | Prognosis | Fu F et al. Transl Oncol. 2018 |
| 1987 | hsa-mir-449a | Colon, Rectum | Diagnosis, Prognosis | Feng Y et al. Oncol Rep. 2018 |
| 1998 | hsa-mir-6852 | Colon, Rectum | Prognosis | Cui BH et al. Exp Ther Med. 2018 |
| 2003 | SNP rs2682818 in hsa-mir-618 | Colon, Rectum | Diagnosis, Treatment | Chen Y et al. Cancer Med. 2018 |
| 2004 | hsa-mir-7e-5p | Rectum | Prognosis | Chen W et al. Oncol Lett. 2018 |
| 2008 | hsa-mir-92a | Colon, Rectum | Prognosis | Chen E et al. Biomed Pharmacother. 2018 |
| 2016 | hsa-mir-338-5p | Colon, Rectum | Diagnosis | Bilegsaikhan E et al. J Dig Dis. 2018 |
| 2022 | hsa-mir-185 | Colon, Rectum | Prognosis | Afshar S et al. Biomed Pharmacother. 2018 |
| 2048 | hsa-mir-122 | Colon, Rectum | Diagnosis, Prognosis | Sun, L et al. J Cancer. 2020 |
| 2050 | hsa-mir-485-5p | Colon, Rectum | Prognosis | Pan, Y et al. Biomark Med. 2020 |
| 2074 | hsa-mir-200a-3p | Colon, Rectum | Diagnosis, Prognosis | Di, Z et al. Front Genet. 2020 |
| 2080 | hsa-mir-142-5p | Rectum | Diagnosis | Kunigenas, L et al. Biomolecules. 2020 |
| 2101 | hsa-mir-92a-1 | Colon, Rectum | Diagnosis | Shi, Y. and Liu, Z et al. J Cell Mol Med. 2020 |
| 2112 | hsa-mir-139-3p | Colon, Rectum | Diagnosis, Prognosis | Liu, W et al. J Cancer. 2020 |
| 2120 | hsa-mir-203a-3p, hsa-mir-145-5p, hsa-mir-375-3p, hsa-mir-200c-3p | Colon, Rectum | Diagnosis | Huang, G et al. Biomark Med. 2020 |
| 2125 | hsa-mir-592 | Colon, Rectum | Diagnosis | Pan, Z et al. Oncol Lett. 2020 |
| 2146 | hsa-mir-451a | Colon, Rectum | Diagnosis | Zhang, Z et al. Biomed Res Int. 2020 |
| 2147 | hsa-mir-30e-3p, hsa-mir-146a-5p, hsa-mir-148a-3p | Colon, Rectum | Diagnosis | Peng, X et al. Int J Biol Markers. 2020 |
| 2151 | hsa-mir-135b-5p | Colon, Rectum | Diagnosis | Li, L et al. Life Sci. 2020 |
| 2210 | hsa-mir-1539 | Colon, Rectum | Prognosis | Cui, X et al. Front Oncol. 2020 |
| 2230 | hsa-mir-33a-5p | Colon, Rectum | Prognosis | Tanaka, S et al. Biochem Biophys Rep. 2021 |
| 2243 | hsa-mir-33a‑5p | Colon, Rectum | Prognosis | Sasaki, M et al. Oncol Lett. 2021 |
| 2262 | hsa-mir-3614-5p | Colon, Rectum | Prognosis | Han, L et al. Front Genet. 2021 |
| 2283 | hsa-mir-21- 5p | Colon, Rectum | Prognosis | Fukada, M et al. Cancer Sci. 2021 |
| 2295 | hsa-mir-5197-5p | Colon, Rectum | Prognosis | Yu, S et al. Front Oncol. 2021 |
| 2308 | hsa-mir-199b | Rectum | Prognosis | Cristóbal, I et al. Cancers (Basel). 2021 |
| 2325 | hsa-mir-30e | Rectum | Prognosis | Chen, W. and Wang, W et al. Genet Test Mol Biomarkers. 2021 |
| 2347 | hsa-mir-129-1-3p, hsa-mir-566 | Colon, Rectum | Diagnosis | Iwasaki, H et al. Cancers (Basel). 2022 |
| 2351 | hsa-mir-133b | Colon, Rectum | Diagnosis | Xie, B et al. Transl Cancer Res. 2021 |
| 2365 | hsa-mir-199b | Rectum | Prognosis | Santos, A et al. Int J Mol Sci. 2022 |
| 2376 | hsa-mir-509-3p | Colon, Rectum | Prognosis | Iyer, D. N et al. BMC Cancer. 2022 |
| 2398 | hsa-mir-3937 | Colon, Rectum | Diagnosis, Treatment | Qiao, D et al. J Oncol. 2022 |
| 2412 | hsa-mir-17-5p, hsa-mir-20a-5p, hsa-mir-30a-5p, hsa-mir-92a-3p, hsa-mir-92b-3p, hsa-mir-98-5p | Colon, Rectum | Prognosis, Treatment | Poel, D et al. Cancer Med. 2020 |
| 2413 | hsa-mir-21 | Rectum | Prognosis | Ourô, S et al. Pharmaceuticals (Basel). 2020 |
| 2424 | hsa-mir-106 | Colon, Rectum | Diagnosis, Prognosis | Peng, Q et al. BMC Cancer. 2020 |
| 2427 | hsa-mir-203 | Colon, Rectum | Prognosis | Peng, Q et al. BMC Cancer. 2020 |
| 2431 | hsa-mir-92a | Colon, Rectum | Diagnosis, Prognosis | Peng, Q et al. J Cancer. 2019 |
| 2433 | hsa-mir-200s | Colon, Rectum | Prognosis | Peng, Q et al. Cancer Cell Int. 2020 |
| 2436 | hsa-mir-200 | Colon, Rectum | Prognosis | Yu, C et al. J Cancer. 2019 |